JP3803587B2 - 鏡像異性的に純粋な１，３−ジオキソラン−４−オン誘導体若しくは１，３−オキサチオラン−５−オン−誘導体の酵素的製造方法 - Google Patents
鏡像異性的に純粋な１，３−ジオキソラン−４−オン誘導体若しくは１，３−オキサチオラン−５−オン−誘導体の酵素的製造方法 Download PDFInfo
- Publication number
- JP3803587B2 JP3803587B2 JP2002022091A JP2002022091A JP3803587B2 JP 3803587 B2 JP3803587 B2 JP 3803587B2 JP 2002022091 A JP2002022091 A JP 2002022091A JP 2002022091 A JP2002022091 A JP 2002022091A JP 3803587 B2 JP3803587 B2 JP 3803587B2
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkenyl
- aryl
- heteroaryl
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- GZTMCZAOQTVOJK-UHFFFAOYSA-N 1,3-dioxolan-4-one Chemical class O=C1COCO1 GZTMCZAOQTVOJK-UHFFFAOYSA-N 0.000 title claims abstract description 20
- FYAVYWUBPQMCQN-UHFFFAOYSA-N 1,3-oxathiolan-5-one Chemical class O=C1CSCO1 FYAVYWUBPQMCQN-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 230000002255 enzymatic effect Effects 0.000 title description 5
- 108090000790 Enzymes Proteins 0.000 claims abstract description 31
- 102000004190 Enzymes Human genes 0.000 claims abstract description 31
- 239000012038 nucleophile Substances 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 17
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 230000008569 process Effects 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 108090000371 Esterases Proteins 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims description 8
- 108090001060 Lipase Proteins 0.000 claims description 8
- 102000004882 Lipase Human genes 0.000 claims description 8
- 239000004367 Lipase Substances 0.000 claims description 8
- 235000019421 lipase Nutrition 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 238000003776 cleavage reaction Methods 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 230000007017 scission Effects 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000006227 byproduct Substances 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 229910052717 sulfur Chemical group 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 150000008282 halocarbons Chemical class 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- 239000006184 cosolvent Substances 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 1
- 238000005336 cracking Methods 0.000 claims 1
- 125000004474 heteroalkylene group Chemical group 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 24
- 239000002777 nucleoside Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- PLACRQSTXTULHS-UHFFFAOYSA-N oxathiolan-3-one Chemical compound O=C1CCOS1 PLACRQSTXTULHS-UHFFFAOYSA-N 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001728 carbonyl compounds Chemical class 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000003833 nucleoside derivatives Chemical class 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 241001661345 Moesziomyces antarcticus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N alpha-isobutyric acid Natural products CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001656 butanoic acid esters Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960000366 emtricitabine Drugs 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- KFHQOZXAFUKFNB-UHFFFAOYSA-N 1,3-oxathiolanyl Chemical group [CH]1OCCS1 KFHQOZXAFUKFNB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BCAWWPAPHSAUQZ-RNFRBKRXSA-N 1-[(2r,4r)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)OC1 BCAWWPAPHSAUQZ-RNFRBKRXSA-N 0.000 description 1
- 241000588810 Alcaligenes sp. Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000146387 Chromobacterium viscosum Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 241000222175 Diutina rugosa Species 0.000 description 1
- 101100440640 Drosophila melanogaster conu gene Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 241000193390 Parageobacillus thermoglucosidasius Species 0.000 description 1
- 244000271379 Penicillium camembertii Species 0.000 description 1
- 235000002245 Penicillium camembertii Nutrition 0.000 description 1
- 240000000064 Penicillium roqueforti Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000235545 Rhizopus niveus Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000003508 chemical denaturation Methods 0.000 description 1
- 238000005356 chiral GC Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- LLYJISDUHFXOHK-GOCONZMPSA-N ferroptocide Chemical compound C[C@@H]1CC[C@@]23C[C@@H](C(=O)[C@]2([C@@]1([C@@H](C[C@H]([C@@H]3C)C4=CCN5C(=O)N(C(=O)N5C4)C6=CC=CC=C6)OC(=O)CCl)C)O)O LLYJISDUHFXOHK-GOCONZMPSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000005375 organosiloxane group Chemical group 0.000 description 1
- VBQDMVOVSDFIJJ-UHFFFAOYSA-N oxathiolan-5-one Chemical class O=C1CCSO1 VBQDMVOVSDFIJJ-UHFFFAOYSA-N 0.000 description 1
- OOFGXDQWDNJDIS-UHFFFAOYSA-N oxathiolane Chemical group C1COSC1 OOFGXDQWDNJDIS-UHFFFAOYSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Extraction Or Liquid Replacement (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10104231A DE10104231A1 (de) | 2001-01-31 | 2001-01-31 | Verfahren zur enzymatischen Herstellung von enantiomerenreinen 1,3-Dioxolan-4-on-Derivaten |
| DE10104231.0 | 2001-01-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002281997A JP2002281997A (ja) | 2002-10-02 |
| JP3803587B2 true JP3803587B2 (ja) | 2006-08-02 |
Family
ID=7672286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002022091A Expired - Fee Related JP3803587B2 (ja) | 2001-01-31 | 2002-01-30 | 鏡像異性的に純粋な１，３−ジオキソラン−４−オン誘導体若しくは１，３−オキサチオラン−５−オン−誘導体の酵素的製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6887700B2 (de) |
| EP (1) | EP1229127B1 (de) |
| JP (1) | JP3803587B2 (de) |
| AT (1) | ATE304606T1 (de) |
| CA (1) | CA2369718A1 (de) |
| DE (2) | DE10104231A1 (de) |
| ES (1) | ES2246355T3 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10232780A1 (de) * | 2002-07-18 | 2004-02-12 | Basf Ag | Co-Tenside auf Basis von Aldehyden |
| US8884034B2 (en) | 2009-07-08 | 2014-11-11 | Dermira (Canada), Inc. | TOFA analogs useful in treating dermatological disorders or conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| NZ241625A (en) | 1991-02-22 | 1996-03-26 | Univ Emory | 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers |
| CN100351389C (zh) * | 1998-10-09 | 2007-11-28 | 爱尔特斯制药公司 | 用于拆分对映体混合物的非均相体系 |
-
2001
- 2001-01-31 DE DE10104231A patent/DE10104231A1/de not_active Withdrawn
-
2002
- 2002-01-24 EP EP02001124A patent/EP1229127B1/de not_active Expired - Lifetime
- 2002-01-24 AT AT02001124T patent/ATE304606T1/de not_active IP Right Cessation
- 2002-01-24 DE DE50204211T patent/DE50204211D1/de not_active Expired - Fee Related
- 2002-01-24 ES ES02001124T patent/ES2246355T3/es not_active Expired - Lifetime
- 2002-01-30 US US10/059,774 patent/US6887700B2/en not_active Expired - Fee Related
- 2002-01-30 JP JP2002022091A patent/JP3803587B2/ja not_active Expired - Fee Related
- 2002-01-30 CA CA002369718A patent/CA2369718A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE304606T1 (de) | 2005-09-15 |
| JP2002281997A (ja) | 2002-10-02 |
| US6887700B2 (en) | 2005-05-03 |
| ES2246355T3 (es) | 2006-02-16 |
| EP1229127A1 (de) | 2002-08-07 |
| DE10104231A1 (de) | 2002-08-08 |
| EP1229127B1 (de) | 2005-09-14 |
| CA2369718A1 (en) | 2002-07-31 |
| US20030143698A1 (en) | 2003-07-31 |
| DE50204211D1 (de) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3625236B1 (de) | Herstellprozess für ein optisch aktives cineol-derivat | |
| US20080038802A1 (en) | Method of Making Optically Active Ester Derivatives and Their Acids From Racemic Esters | |
| US5084392A (en) | Process for producing optically active hydroxy lactones | |
| Snead et al. | An economical route to lamivudine featuring a novel strategy for stereospecific assembly | |
| JP3803587B2 (ja) | 鏡像異性的に純粋な１，３−ジオキソラン−４−オン誘導体若しくは１，３−オキサチオラン−５−オン−誘導体の酵素的製造方法 | |
| Jacobsen et al. | Lipase catalysed kinetic resolution of stiripentol | |
| US8546114B2 (en) | Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom | |
| JPH07507200A (ja) | ピラノン | |
| EP2218788B1 (de) | Verfahren zur Herstellung von optisch aktiven Cyclopentenonen | |
| JP2005520570A5 (de) | ||
| KR101399551B1 (ko) | 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온 | |
| Matsumoto et al. | Enzyme-mediated enantioselective hydrolysis of cyclic carbonates bearing an unsaturated substituent | |
| JP2003299495A (ja) | 光学活性３−メチルグルタル酸モノエステルの製造方法 | |
| KR100758512B1 (ko) | 효소적 방법에 의한 광학활성3-히드록시-3-페닐프로피온산과 광학활성3-아실옥시-3-페닐프로피온산의 제조 방법 | |
| EP2069516B1 (de) | Spezifische hydrolyse des ungeschützten (r)-esters von (3)-amino-3-arylpropionsäureestern | |
| JP3095539B2 (ja) | 光学活性α，β−エポキシカルボン酸およびそのエステルの製造法 | |
| JP3545442B2 (ja) | 光学活性４−（２−ハロ−１−ヒドロキシエチル）−２−トリフルオロメチルチアゾールの製造方法 | |
| BR102021022464A2 (pt) | Processo de preparação enantiosseletiva de 1,2-dióis e compostos relacionados e conversão em seus derivados carbonatados e esterificados | |
| JP3970898B2 (ja) | 光学活性α−メチルアルカンジカルボン酸−ω−モノエステル及びその対掌体ジエステルを製造する方法 | |
| US20030109029A1 (en) | Process for the preparation of enantiomerically pure tertiary ss-hydroxycarboxylic acids or their esters | |
| JP2006061112A (ja) | 光学活性な２−（シクロペンチルメチル）−マロン酸モノエステルの製造方法 | |
| Bosetti et al. | Lipase-catalyzed resolution of 1, 2-diols | |
| JPH02238896A (ja) | 光学活性α―トリフルオロメチルカルボン酸の製造方法 | |
| JPH05103690A (ja) | 光学活性２−シクロヘキセニル酢酸及びそのエステルの製造方法 | |
| WO2007072753A1 (ja) | 光学活性な３－（３－ヒドロキシフェニル）－２－アルコキシプロパン酸又はそのエステルの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050414 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050711 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051014 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051216 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060313 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060405 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060508 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |